Items where authors include "Hiley, C."

Article

Fornacon-Wood, I., Banfill, K., Ahmad, S. et al. (22 more authors) (2023) Impact of the COVID-19 pandemic on outcomes for patients with lung cancer receiving curative-intent radiotherapy in the UK. Clinical Oncology, 35 (10). e593-e600. ISSN 0936-6555

Horne, A., Brown, S., Butterworth, K. et al. (26 more authors) (2022) EP05.01-007 CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology, 17 (9). s267-s268. ISSN 1556-0864

Wu, Y. orcid.org/0000-0003-4080-3935, Biswas, D. orcid.org/0000-0001-9141-5188, Usaite, I. et al. (302 more authors) (2022) A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer. Nature Cancer, 3. pp. 696-709. ISSN 2662-1347

Banfill, K., Croxford, W., Fornacon-Wood, I. et al. (22 more authors) (2022) Changes in the management of patients having radical radiotherapy for lung cancer during the first wave of the COVID-19 pandemic in the UK. Clinical Oncology, 34 (1). pp. 19-27. ISSN 0936-6555

Punjabi, A., Barrett, E., Cheng, A. et al. (21 more authors) (2021) Neutrophil–lymphocyte ratio and absolute lymphocyte count as prognostic markers in patients treated with curative-intent radiotherapy for non-small cell lung cancer. Clinical Oncology, 33 (8). e331-e338. ISSN 0936-6555

Evison, M., Barrett, E., Cheng, A. et al. (20 more authors) (2021) Predicting the risk of disease recurrence and death following curative-intent radiotherapy for non-small cell lung cancer: The development and validation of two scoring systems from a large multicentre UK cohort. Clinical Oncology, 33 (3). pp. 145-154. ISSN 0936-6555

Faivre-Finn, C., Fenwick, J.D., Franks, K.N. et al. (11 more authors) (2020) Reduced fractionation in lung cancer patients treated with curative-intent radiotherapy during the COVID-19 pandemic. Clinical Oncology, 32 (8). pp. 481-489. ISSN 0936-6555

Arce Vargas, F., Furness, A.J.S., Litchfield, K. et al. (249 more authors) (2018) Fc effector function contributes to the activity of human anti-CTLA-4 antibodies. Cancer Cell, 33 (4). 649-663.e4. ISSN 1535-6108

McGranahan, N., Rosenthal, R., Hiley, C.T. et al. (93 more authors) (2017) Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution. Cell, 171 (6). 1259-1271.e11. ISSN 0092-8674

Conference or Workshop Item

Horne, A., Ali, A., Brown, S. et al. (28 more authors) (2022) 153 CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC). In: 20th Annual British Thoracic Oncology Group Conference 2022, 27-28 Jan 2022, Virtual.

Proceedings Paper

Woolf, D., Downs, N., Sutton, C. et al. (15 more authors) (2024) 209 ThOracic Umbrella RadIotherapy STudy in stage IV NSCLC: TOURIST. In: Lung Cancer. 22nd Annual British Thoracic Oncology Group Conference 2024, 17-19 Apr 2024, Belfast, Northern Ireland. Elsevier BV .

Horne, A., Brown, S., Coyle, V. et al. (13 more authors) (2023) P2.01-04 An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC. In: Journal of Thoracic Oncology. 2023 World Conference on Lung Cancer, 09-12 Sep 2023, Singapore. Elsevier BV , S296-S297.

Horne, A., Brown, S., Coyle, V. et al. (13 more authors) (2023) An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC. In: Journal of Thoracic Oncology. 2023 World Conference on Lung Cancer, 09-12 Sep 2023, Singapore. Elsevier , S296-S297.